Gulyukin M I, Kapustina O V, Ezdakova I Y, Valtsiferova S V, Stepanova T V, Anoyatbekov M
Federal Scientific Centre VIEV, Moscow, 109428, Russian Federation.
Vopr Virusol. 2019;64(4):173-177. doi: 10.36233/0507-4088-2019-64-4-173-177.
Bovine leukemia is a widespread infection worldwide, the causative agent of which is the bovine leukemia virus (BLV) in structural structure and functional features similar to human T-cell leukemia virus (HTLV-1 and HTLV-2) and It is considered as an actual medical and social problem. The study of the immune response in experimentally infected calves at an early stage of the disease development, synthesis of specific antibodies of classes G and M (IgG and IgM), diagnostic informativeness of detection of IgM in cattle leukemia is relevant and determines the purpose of this study.
Samples of blood and serum of cattle: animals experimentally infected with VLCRS, patients with cattle leukemia; control negative; specific to heterologous pathogens of cattle diseases. Indirect and sandwich variant enzyme-linked immunosorbent assay (ELISA); commercial ELISA kits (IDEXX, USA; Hema LLC, FKP Kursk Biofactory Firm BIOK, Russia) for the detection of specific IgG and IgM for BLV in the agar gel immunodiffusion reaction (RID).
The humoral immune response develops shortly after infection - by 1-8 weeks. IgM are detected starting from the 3 day, and IgG from the 7th day after infection. Up to 97% of coincidence of positive results in RID and indirect variant of TF ELISA based on monoclonal antibodies to cattle IgM (IgM) were found.
The dynamics of the synthesis of antibodies of classes M and G to the glycoprotein gp 51 BLV has a dosedependent wave-like character, is consistent with the levels of increase / decrease in the absolute and relative number of leukocytes / blood lymphocytes of infected calves.
Serum specific IgM was detected starting 3 days after infection with BLV. Early detection of IgM in serum of cattle can be used as an additional test for the detection of sick animals.
牛白血病是一种在全球广泛传播的感染病,其病原体是牛白血病病毒(BLV),在结构和功能特征上与人类T细胞白血病病毒(HTLV - 1和HTLV - 2)相似,它被视为一个实际的医学和社会问题。研究疾病发展早期实验感染小牛的免疫反应、合成G类和M类特异性抗体(IgG和IgM)以及检测牛白血病中IgM的诊断信息价值具有相关性,并确定了本研究的目的。
牛的血液和血清样本:实验感染VLCRS的动物、患牛白血病的病牛;阴性对照;针对牛病异源病原体的样本。间接和夹心变体酶联免疫吸附测定(ELISA);用于在琼脂凝胶免疫扩散反应(RID)中检测针对BLV的特异性IgG和IgM的商业ELISA试剂盒(美国IDEXX公司;俄罗斯库尔斯科生物工厂FKP库尔斯克生物公司Hema LLC)。
感染后不久即1 - 8周会产生体液免疫反应。感染后第3天开始检测到IgM,第7天开始检测到IgG。基于针对牛IgM(IgM)的单克隆抗体,发现RID和间接变体TF ELISA的阳性结果高达97%相符。
针对BLV糖蛋白gp 51的M类和G类抗体合成动态具有剂量依赖性波浪状特征,与感染小牛白细胞/血液淋巴细胞绝对和相对数量的增减水平一致。
感染BLV后3天开始检测到血清特异性IgM。早期检测牛血清中的IgM可作为检测患病动物的一项附加检测方法。